Dabigatran [dabigatran]
- Terms
-
dabigatran etexilát
dabigatran etexilát mesylát
dabigatran-etexilát
Pradaxa
-
BIBR 1048
Dabigatran Etexilate
Dabigatran Etexilate Mesylate
N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine
Pradaxa
A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
- DUI
- D000069604 MeSH Browser
- CUI
- M0553211
- RN
- I0VM4M70GC
- History note
- 2016 (2002)
- Public note
- 2016; DABIGATRAN was indexed under BENZIMIDOAZOLES and BETA-ALANINE 2010-2015; DABIGATRAN ETEXILATE was indexed under BENZIMIDOAZOLES and PYRIDINES 2002-2015
Allowable subheadings
- AD
- administration & dosage 92
- AE
- adverse effects 84
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 3
- AI
- antagonists & inhibitors 7
- BL
- blood 4
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 1
- CL
- classification 0
- EC
- economics 3
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 1
- PK
- pharmacokinetics 26
- PD
- pharmacology 63
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 139
- TO
- toxicity 0
- UR
- urine 0